Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646) [Phase 1]